Gene therapy

Combining gene editing and RNAi for advanced therapies

Read more

A business model for cell and gene therapies

Read more

Why synthetic gene promoters matter

Read more

Trends in investment for cell and gene therapies

Read more

AAV-based gene therapies poised for uplift

Read more

Caszyme pioneers gene editing from Lithuania

Read more

Changes in the landscape for genome editing

Read more

Genome editing for inherited ocular diseases

Read more

The outlook for gene editing in treating disease

Read more

WHO panel advises on governance of genome editing

Read more